The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract.
 
Simon Crabb
Honoraria - AstraZeneca; Bristol Myers Squibb; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Amgen; Amphista Therapeutics; AstraZeneca; Bayer; Janssen; Merck; MSD; Pfizer
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche
Travel, Accommodations, Expenses - Bayer; Janssen; Merck
 
Jonathan Martin
No Relationships to Disclose
 
Megan Lawrence
No Relationships to Disclose
 
Mary Danh
No Relationships to Disclose
 
Sarah-Jane Bibby
No Relationships to Disclose
 
Denise Dunkley
No Relationships to Disclose
 
Uroosha Ali
No Relationships to Disclose
 
Oli Dewane
No Relationships to Disclose
 
Hannah Markham
No Relationships to Disclose
 
Allen Knight
No Relationships to Disclose
 
Cheng Lee Chaw
No Relationships to Disclose
 
Joachim Chan
No Relationships to Disclose
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Jim Barber
No Relationships to Disclose
 
Constantine Alifrangis
No Relationships to Disclose
 
Mark Linch
Consulting or Advisory Role - ADC Therapeutics; Astellas Pharma; AstraZeneca; Bicycle Therapeutics; BioNTech; Bristol-Myers Squibb; Janssen Oncology; Merck Serono; Pfizer/EMD Serono
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - bristol myers squibb; Janssen; Merck; MSD
 
Robert Huddart
Leadership - Cancer clinic london Limited liability partnership
Consulting or Advisory Role - Bayer; BioNTech SE; Gilead Sciences; Janssen; Janssen Oncology; Merck; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - Bristol Myers Squibb Foundation; Pfizer
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Janssen; Nektar; Roche/Genentech
 
Alison Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Bristol-Myers-Squib; Janssen Oncology; Merck Serono; Pfizer; Roche; Sanofi
Speakers' Bureau - Bayer; Janssen Oncology; Merck; Pfizer
Research Funding - Genzyme
 
Robert Jones
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Elsevier; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech; WebMD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; IPSEN; Janssen; Merck Serono; MSD Oncology; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD; Pfizer
 
Gareth Griffiths
Honoraria - Abbvie; AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Heartflow (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)